Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Gerald Batist et al.|The Lancet|2020Cited by 1.8k
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort StudyDonna R. Rivera, Jeremy L. Warner, Solange Peters et al.|Cancer Discovery|2020Cited by 138
B7-H3 as a Therapeutic Target in Advanced Prostate CancerChristina Guo, Johann S. de Bono, Ines Figueiredo et al.|European Urology|2022Cited by 90
Safety and clinical activity of BMS-986365 (CC-94676), a dual androgen receptor ligand-directed degrader and antagonist, in heavily pretreated patients with metastatic castration-resistant prostate cancerDana E. Rathkopf, Andrew J. Armstrong, Manish R. Patel et al.|Annals of Oncology|2024Cited by 66
Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York CityKevin Kalinsky, Dawn L. Hershman, Melissa Accordino et al.|Breast Cancer Research and Treatment|2020Cited by 58